SDCCQ vs. BIOL, IONM, VRAYQ, AHPI, BRSH, MOTS, VIVE, DRTSW, ANZUW, and ATAKW
Should you be buying SmileDirectClub stock or one of its competitors? The main competitors of SmileDirectClub include BIOLASE (BIOL), Assure (IONM), ViewRay (VRAYQ), Allied Healthcare Products (AHPI), Bruush Oral Care (BRSH), Motus GI (MOTS), Viveve Medical (VIVE), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), and Aurora Technology Acquisition (ATAKW). These companies are all part of the "medical equipment" industry.
SmileDirectClub vs.
BIOLASE (NASDAQ:BIOL) and SmileDirectClub (NASDAQ:SDCCQ) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, dividends, profitability, media sentiment, valuation, institutional ownership, analyst recommendations, community ranking and earnings.
In the previous week, BIOLASE had 1 more articles in the media than SmileDirectClub. MarketBeat recorded 1 mentions for BIOLASE and 0 mentions for SmileDirectClub. BIOLASE's average media sentiment score of 0.00 equaled SmileDirectClub'saverage media sentiment score.
SmileDirectClub has a net margin of 0.00% compared to BIOLASE's net margin of -41.65%. SmileDirectClub's return on equity of 0.00% beat BIOLASE's return on equity.
BIOLASE has a beta of 0.67, indicating that its stock price is 33% less volatile than the S&P 500. Comparatively, SmileDirectClub has a beta of 2.02, indicating that its stock price is 102% more volatile than the S&P 500.
BIOLASE presently has a consensus target price of $1.20, indicating a potential upside of 13,693.10%. Given BIOLASE's stronger consensus rating and higher probable upside, equities research analysts clearly believe BIOLASE is more favorable than SmileDirectClub.
BIOLASE received 292 more outperform votes than SmileDirectClub when rated by MarketBeat users.
8.8% of BIOLASE shares are owned by institutional investors. Comparatively, 0.1% of SmileDirectClub shares are owned by institutional investors. 0.3% of BIOLASE shares are owned by insiders. Comparatively, 64.7% of SmileDirectClub shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
BIOLASE has higher earnings, but lower revenue than SmileDirectClub.
Summary
BIOLASE beats SmileDirectClub on 8 of the 14 factors compared between the two stocks.
Get SmileDirectClub News Delivered to You Automatically
Sign up to receive the latest news and ratings for SDCCQ and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
SDCCQ vs. The Competition
SmileDirectClub Competitors List
Related Companies and Tools
This page (NASDAQ:SDCCQ) was last updated on 2/22/2025 by MarketBeat.com Staff
